The role of routine and novel biomarkers and their correlation with clinical outcome measures in patients undergoing surgical interventions for benign and malignant disorders of the prostate and bladder.

• Inclusion Criteria :
  • All patients scheduled for elective surgery for the treatment of benign and malignant hyperplasia of the prostate, bladder and penis will be considered for participation in this research
• Exclusion Criteria :
  • Patients will be excluded from the study if informed consent is not obtained
  • Following informed consent the patient may withdraw from the study at any time
  • If blood samples are unobtainable during venepuncture or following surgery then the patient will be withdrawn from the study.
  • Patients with underlying chronic inflammatory and cardiovascular disorders (e.g. rheumatoid arthritis, ischaemic heart disease) will not be excluded from the study. A baseline/control sample will be collected (preoperatively) to assess each individual's postoperative response and the results will therefore be relevant to this study.
• Study start date : 01/04/2015
• Study end date : 30/06/2024
• Wales-Based Study Contact : Prof Iqbal Shergill

Contact details

Wrexham uroemerge@yahoo.co.uk